1,000
Participants
Start Date
February 29, 2008
Primary Completion Date
June 30, 2010
Study Completion Date
December 31, 2010
Treatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamide
initial treatment with a low dose diuretic/ACE-inhibitor or ARB combination followed by a low dose DHP-CCB/statin combination
Robarts Research Insititute, London
Collaborators (1)
Pfizer
INDUSTRY
University of Western Ontario, Canada
OTHER